Correlation Between Bone Biologics and Singular Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and Singular Genomics Systems, you can compare the effects of market volatilities on Bone Biologics and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Singular Genomics.

Diversification Opportunities for Bone Biologics and Singular Genomics

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bone and Singular is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of Bone Biologics i.e., Bone Biologics and Singular Genomics go up and down completely randomly.

Pair Corralation between Bone Biologics and Singular Genomics

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the Singular Genomics. In addition to that, Bone Biologics is 17.94 times more volatile than Singular Genomics Systems. It trades about -0.02 of its total potential returns per unit of risk. Singular Genomics Systems is currently generating about 0.16 per unit of volatility. If you would invest  1,982  in Singular Genomics Systems on November 28, 2024 and sell it today you would earn a total of  19.00  from holding Singular Genomics Systems or generate 0.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Bone Biologics Corp  vs.  Singular Genomics Systems

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Singular Genomics Systems 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Singular Genomics Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Bone Biologics and Singular Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and Singular Genomics

The main advantage of trading using opposite Bone Biologics and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.
The idea behind Bone Biologics Corp and Singular Genomics Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stocks Directory
Find actively traded stocks across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences